Mammography QA Standards Contemplated By JAMA Study Authors
This article was originally published in The Gray Sheet
The value of mandatory hospital quality measures, long championed by CMS Administrator Tom Scully, is supported by a study comparing U.S. mammography screening practices with those in the UK
You may also be interested in...
CMS is curbing device prices by setting reimbursement levels for new technology at slightly lower rates than the prices charged by manufacturers, according to Administrator Tom Scully
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.